Cue Biopharma, Inc. (CUE)
NASDAQ·Healthcare·Biotechnology
$24.51
-9.54%
Mkt Cap $47.12M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$4.33
Range $2.00 – $7.00
Implied Upside
-82.3%
Consensus $4.33 vs current $24.51
NASDAQ·Healthcare·Biotechnology
$24.51
-9.54%
Mkt Cap $47.12M
No recent rating data.
Price Target (4 analysts)
$4.33
Range $2.00 – $7.00
-82.3%
Consensus $4.33 vs current $24.51